Providing Real-time Interaction Between Users and Providers of Genetically Characterized Blood Products
Abstract
Disclosed is a registry system, including member institutions, in which transfusion donors and recipients are registered following genotyping, which would typically take place in a member institution, or a member institution would have access to the genotyping information, if performed outside. The registry database can be accessed and searched by members seeking samples of particular type(s). Systems are disclosed for maintaining economic viability of genotyping in connection with transfusions, by maximizing the number of units placed with the minimal number of candidate donors typed. Genotyping of potential donors, and product supply, is matched to forecasted demand. Genotyping can also be limited to the more clinically relevant markers. The registry system can also be Integrated with one format of assay which generates an image for analysis, whereby the imaged results can be analyzed and redacted by experts in a central location, and then transmitted back to the patient or their representative.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A strategy for operating a registry offering access to genotyped prospective transfusion donors, for matching to a transfusion recipient of given genotype or phenotype, in a manner increasing the probability of having an acceptable donor for any recipient querying the registry while decreasing the total number of prospective donors to be typed, comprising:
stratifying prospective donors and recipients into subpopulations; and for each subpopulation, tying sufficient numbers of donors of different types to reflect anticipated demand from recipients of particular types.
2 - 19 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.